Related references
Note: Only part of the references are listed.Small-Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4-Amino-1,2,4-triazole-3-thiol Scaffold
Margaret E. Olson et al.
CHEMMEDCHEM (2013)
Genetic Variants in the Host Restriction Factor APOBEC3G are Associated With HIV-1-Related Disease Progression and Central Nervous System Impairment in Children
Kumud K. Singh et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic
Allison M. Land et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population
S. Ezzikouri et al.
JOURNAL OF VIRAL HEPATITIS (2013)
APOBEC3G Restricts HIV-1 to a Greater Extent than APOBEC3F and APOBEC3DE in Human Primary CD4+ T Cells and Macrophages
Chawaree Chaipan et al.
JOURNAL OF VIROLOGY (2013)
Suppression of HIV-1 Infection by APOBEC3 Proteins in Primary Human CD4+ T Cells Is Associated with Inhibition of Processive Reverse Transcription as Well as Excessive Cytidine Deamination
Kieran Gillick et al.
JOURNAL OF VIROLOGY (2013)
APOBEC3B is an enzymatic source of mutation in breast cancer
Michael B. Burns et al.
NATURE (2013)
First-In-Class Small Molecule Inhibitors of the Single-Strand DNA Cytosine Deaminase APOBEC3G
Ming Li et al.
ACS CHEMICAL BIOLOGY (2012)
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure
Slim Fourati et al.
AIDS (2012)
APOBEC3-Mediated Editing in HIV Type 1 from Pediatric Patients and Its Association with APOBEC3G/CUL5 Polymorphisms and Vif Variability
Federico A. De Maio et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Creative deaminases, self-inflicted damage, and genome evolution
Silvestro G. Conticello
EFFECTS OF GENOME STRUCTURE AND SEQUENCE ON VARIATION AND EVOLUTION (2012)
A Virological View of Innate Immune Recognition
Akiko Iwasaki
ANNUAL REVIEW OF MICROBIOLOGY, VOL 66 (2012)
APOBEC3B and AID Have Similar Nuclear Import Mechanisms
Lela Lackey et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1
Marcel Ooms et al.
JOURNAL OF VIROLOGY (2012)
HIV-1 Replication and APOBEC3 Antiviral Activity Are Not Regulated by P Bodies
Prabhjeet K. Phalora et al.
JOURNAL OF VIROLOGY (2012)
The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function during Viral Replication
Xiaoxia Wang et al.
JOURNAL OF VIROLOGY (2012)
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
Satish K. Pillai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The role of G protein gene GNB3 C825T Polymorphism in HIV-1 acquisition, progression and immune activation
Jennifer Juno et al.
RETROVIROLOGY (2012)
Functions and regulation of the APOBEC family of proteins
Harold C. Smith et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo
Yordanka Kourteva et al.
VIROLOGY (2012)
Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein
Carsten Muenk et al.
VIRUSES-BASEL (2012)
Loci Polymorphisms of the APOBEC3G Gene in HIV Type 1-Infected Brazilians
Maria Clara Bizinoto et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Cutaneous Infections Caused by Herpesviridae A Review
Cary Chisholm et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast
A. G. Lada et al.
BIOCHEMISTRY-MOSCOW (2011)
Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain
Junjie U. Guo et al.
CELL (2011)
Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients
Maria Angeles Jimenez-Sousa et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2011)
A POSITIVELY SELECTED APOBEC3H HAPLOTYPE IS ASSOCIATED WITH NATURAL RESISTANCE TO HIV-1 INFECTION
Rachele Cagliani et al.
EVOLUTION (2011)
Host Apolipoprotein B Messenger RNA-Editing Enzyme Catalytic Polypeptide-Like 3G Is an Innate Defensive Factor and Drug Target Against Hepatitis C Virus
Zong-Gen Peng et al.
HEPATOLOGY (2011)
APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection
P. A. Gourraud et al.
HUMAN IMMUNOLOGY (2011)
Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms
Federico A. De Maio et al.
INFECTION GENETICS AND EVOLUTION (2011)
An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G
Tomohiko Ejima et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
APOBEC1-Mediated Editing and Attenuation of Herpes Simplex Virus 1 DNA Indicate That Neurons Have an Antiviral Role during Herpes Simplex Encephalitis
Peter Gee et al.
JOURNAL OF VIROLOGY (2011)
Assessment of the Genetic Susceptibility of Sheep to Scrapie by Protein Misfolding Cyclic Amplification and Comparison with Experimental Scrapie Transmission Studies
Cecilia Bucalossi et al.
JOURNAL OF VIROLOGY (2011)
Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo
Rodolphe Suspene et al.
JOURNAL OF VIROLOGY (2011)
Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Xiaojun Wang et al.
JOURNAL OF VIROLOGY (2011)
Analysis of Reptilian APOBEC1 Suggests that RNA Editing May Not Be Its Ancestral Function
Francesco Severi et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells
Jason M. Norman et al.
NATURE IMMUNOLOGY (2011)
Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3′ UTRs
Brad R. Rosenberg et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons
Terumasa Ikeda et al.
NUCLEIC ACIDS RESEARCH (2011)
Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure
Jairam R. Lingappa et al.
PLOS ONE (2011)
Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism
Rodolphe Suspene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Pattern Recognition Receptors and the Innate Immune Response to Viral Infection
Mikayla R. Thompson et al.
VIRUSES-BASEL (2011)
APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
Kavidha Reddy et al.
AIDS (2010)
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
John S. Albin et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
The Associations of hA3G and hA3B mRNA Levels With HIV Disease Progression Among HIV-Infected Individuals of China
Min Zhao et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Deficiency in APOBEC2 Leads to a Shift in Muscle Fiber Type, Diminished Body Mass, and Myopathy
Yusuke Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G
Shan Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells
Nicoletta Casartelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
No Evidence of an Association between the APOBEC3B Deletion Polymorphism and Susceptibility to HIV Infection and AIDS in Japanese and Indian Populations
Sakiko Itaya et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes
Lubbertus C. F. Mulder et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo
Jun Fan et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis
Holly A. Sadler et al.
JOURNAL OF VIROLOGY (2010)
Human APOBEC3G-Mediated Editing Can Promote HIV-1 Sequence Diversification and Accelerate Adaptation to Selective Pressure
Eun-Young Kim et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2010)
Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency
Christian Popp et al.
NATURE (2010)
Reprogramming towards pluripotency requires AID-dependent DNA demethylation
Nidhi Bhutani et al.
NATURE (2010)
Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers
Hongxing Zhang et al.
NATURE GENETICS (2010)
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Mark D. Stenglein et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation
Gaelle Mercenne et al.
NUCLEIC ACIDS RESEARCH (2010)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Host genes associated with HIV/AIDS: advances in gene discovery
Ping An et al.
TRENDS IN GENETICS (2010)
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Priya Kannian et al.
VIRUSES-BASEL (2010)
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
Jean-Pierre Vartanian et al.
PLOS PATHOGENS (2010)
HIV pathogenesis: 25 years of progress and persistent challenges
Jay A. Levy
AIDS (2009)
Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1
Lindi Tan et al.
FASEB JOURNAL (2009)
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS
Judd F. Hultquist et al.
FUTURE VIROLOGY (2009)
Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection
Hiromi Abe et al.
HEPATOLOGY RESEARCH (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
APOBEC3B Deletion and Risk of HIV-1 Acquisition
Ping An et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients
Severine Margeridon-Thermet et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Murine APOBEC1 Is a Powerful Mutator of Retroviral and Cellular RNA In Vitro and In Vivo
Vincent Petit et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H
Ariana Harari et al.
JOURNAL OF VIROLOGY (2009)
Analysis of the Percentage of Human Immunodeficiency Virus Type 1 Sequences That Are Hypermutated and Markers of Disease Progression in a Longitudinal Cohort, Including One Individual with a Partially Defective Vif
Anne Piantadosi et al.
JOURNAL OF VIROLOGY (2009)
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
Yoichiro Kamatani et al.
NATURE GENETICS (2009)
AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity
Donna A. MacDuff et al.
NUCLEIC ACIDS RESEARCH (2009)
Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G
Michel Henry et al.
PLOS ONE (2009)
APOBEC3G-Depleted Resting CD4+ T Cells Remain Refractory to HIV1
Francesca R. Santoni de Sio et al.
PLOS ONE (2009)
APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression
Joel A. Vazquez-Perez et al.
RETROVIROLOGY (2009)
Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
Mohammad A. Khan et al.
RETROVIROLOGY (2009)
Human APOBEC1 cytidine deaminase edits HBV DNA
Minerva Cervantes Gonzalez et al.
RETROVIROLOGY (2009)
Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+T-Cells
Masakazu Kamata et al.
PLOS PATHOGENS (2009)
Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
Patric Jern et al.
PLOS PATHOGENS (2009)
HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC
Natasha Wood et al.
PLOS PATHOGENS (2009)
The Level of APOBEC3G (hA3G)-Related G-to-A Mutations Does Not Correlate with Viral Load in HIV Type 1-Infected Individuals
Nzovu K. Ulenga et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Mucocutaneous manifestations of Epstein-Barr virus infection
Natalia Mendoza et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2008)
The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements
Ya-Lin Chiu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
APOBEC and iNOS are not the main intracellular effectors of IFN-γ-mediated inactivation of Hepatitis B virus replication
Sandra Proto et al.
ANTIVIRAL RESEARCH (2008)
The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals
Rebecca S. Larue et al.
BMC MOLECULAR BIOLOGY (2008)
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution
Molly OhAinle et al.
CELL HOST & MICROBE (2008)
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G
Guylaine Hache et al.
CURRENT BIOLOGY (2008)
Human cytidine deaminase APOBEC3H restricts HIV-1 replication
Ying Dang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H
Josef Koeck et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F
Nzovu K. Ulenga et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya
Allison M. Land et al.
JOURNAL OF VIROLOGY (2008)
Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins
Sarah Gallois-Montbrun et al.
JOURNAL OF VIROLOGY (2008)
Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1
Marc-Andre Langlois et al.
JOURNAL OF VIROLOGY (2008)
Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences
Andrew E. Armitage et al.
JOURNAL OF VIROLOGY (2008)
Small-molecule inhibition of HIV-1 Vif
Robin Nathans et al.
NATURE BIOTECHNOLOGY (2008)
The antiretroviral potency of APOBEC1 deaminase from small animal species
Terumasa Ikeda et al.
NUCLEIC ACIDS RESEARCH (2008)
Cytidine deamination induced HIV-1 drug resistance
Lubbertus C. F. Mulder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Turning up the volume on mutational pressure: Is more of a good thing always better? (A case study of HIV-I Vif and APOBEC3)
Satish K. Pillai et al.
RETROVIROLOGY (2008)
Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions
Jean-Pierre Vartanian et al.
SCIENCE (2008)
Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C
Tao Wang et al.
VIROLOGY (2008)
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells
Jenny L. Anderson et al.
VIROLOGY (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
Functions, structure, and read-through alternative splicing of feline APOBEC3 genes
Carsten Muenk et al.
GENOME BIOLOGY (2008)
Nuclear exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding
Ryan P. Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Absence of H186R polymorphism in Exon 4 of the APOBEC3G gene among North Indian individuals
Anurag Rathore et al.
GENETIC TESTING (2008)
Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression
Wei Zhang et al.
CELLULAR MICROBIOLOGY (2008)
Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma
Rongzhen Xu et al.
HEPATOLOGY (2007)
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Yasumasa Iwatani et al.
NUCLEIC ACIDS RESEARCH (2007)
APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription
Xiao-Yu Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by Interferons
Stephanie Jost et al.
JOURNAL OF VIROLOGY (2007)
Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1
Khaoula Bourara et al.
PLOS PATHOGENS (2007)
Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association
Anna Maria Niewiadomska et al.
JOURNAL OF VIROLOGY (2007)
Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C
Thomas F. Baumert et al.
HEPATOLOGY (2007)
Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant
Sandrine Opi et al.
JOURNAL OF VIROLOGY (2007)
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2007)
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
Kun Luo et al.
JOURNAL OF VIROLOGY (2007)
APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition
G. G. Schumann
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Replication of hepatitis C virus
Darius Moradpour et al.
NATURE REVIEWS MICROBIOLOGY (2007)
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo
Philip J. Ellery et al.
JOURNAL OF IMMUNOLOGY (2007)
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G
David H. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition
Masanobu Kinomoto et al.
NUCLEIC ACIDS RESEARCH (2007)
APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC linker
Atuhani Burnett et al.
JOURNAL OF VIROLOGY (2007)
Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA
Bin Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Selective inhibition of Alu retrotransposition by APOBEC3G
Amy E. Hulme et al.
GENE (2007)
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals
Mara Biasin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Population stratification of a common APOBEC gene deletion polymorphism
Jeffrey M. Kidd et al.
PLOS GENETICS (2007)
Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
David Derse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells
Kim S. Stopak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H
Vanessa B. Soros et al.
PLOS PATHOGENS (2007)
Dual effect of APOBEC3G on Hepatitis B virus
Chiemi Noguchi et al.
JOURNAL OF GENERAL VIROLOGY (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle
Xiaojun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules
Sarah Gallois-Montbrun et al.
JOURNAL OF VIROLOGY (2007)
Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G
Zuoxiang Xiao et al.
FASEB JOURNAL (2007)
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Masao Matsuoka et al.
NATURE REVIEWS CANCER (2007)
Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits
Joseph E. Wedekind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationv
Fei Guo et al.
JOURNAL OF VIROLOGY (2006)
High expression of APOBEC3G in patients infected with hepatitis C virus
Yoshihiro Komohara et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family
Ying Dang et al.
JOURNAL OF VIROLOGY (2006)
High-molecular-mass APOBEC3G complexes restrict alu retrotransposition
Ya-Lin Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians
Han Sang Valcke et al.
AIDS (2006)
The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules
Susan L. Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation
Craig Pace et al.
JOURNAL OF VIROLOGY (2006)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Hal P. Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation
JF Kreisberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes
Y Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count
SJ Cho et al.
JOURNAL OF VIROLOGY (2006)
Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex
K Shirakawa et al.
VIROLOGY (2006)
Viral hepatitis and liver cancer: the case of hepatitis C
M. Levrero
ONCOGENE (2006)
Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G
SM Kaiser et al.
JOURNAL OF VIROLOGY (2006)
Restriction of foamy viruses by APOBEC cytidine deaminases
F Delebecque et al.
JOURNAL OF VIROLOGY (2006)
Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses
C Esnault et al.
NUCLEIC ACIDS RESEARCH (2006)
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
HP Bogerd et al.
NUCLEIC ACIDS RESEARCH (2006)
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
Marianne Bonvin et al.
HEPATOLOGY (2006)
APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia
X Jin et al.
JOURNAL OF VIROLOGY (2005)
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases
B Schröfelbauer et al.
JOURNAL OF VIROLOGY (2005)
Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases
R Mahieux et al.
JOURNAL OF GENERAL VIROLOGY (2005)
APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis
IB Rogozin et al.
CELL CYCLE (2005)
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
BP Doehle et al.
VIROLOGY (2005)
APOBEC-mediated interference with hepadnavirus production
C Rösler et al.
HEPATOLOGY (2005)
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
AJ Schumacher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo
R Suspène et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
APOBEC3G targets human T-cell leukemia virus type 1
A Sasada et al.
RETROVIROLOGY (2005)
被撤回的出版物: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
YL Chiu et al.
NATURE (2005)
Complementary function of the two catalytic domains of APOBEC3G
F Navarro et al.
VIROLOGY (2005)
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases
SG Conticello et al.
MOLECULAR BIOLOGY AND EVOLUTION (2005)
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
C Esnault et al.
NATURE (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort
H Do et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo
RCL Beale et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Inhibition of hepatitis B virus replication by APOBEC3G
P Turelli et al.
SCIENCE (2004)
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
A Mehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1
S Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
APOBEC3G genetic variants and their influence on the progression to AIDS
P An et al.
JOURNAL OF VIROLOGY (2004)
HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles
M Douaisi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 Virions through interactions with viral and nonviral RNAs
ES Svarovskaia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein
TM Alce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
MT Liddament et al.
CURRENT BIOLOGY (2004)
The interaction between HIV-1 Gag and APOBEC3G
S Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
Q Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
APOBEC-mediated editing of viral RNA
KN Bishop et al.
SCIENCE (2004)
Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks
SS Brar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
APOBEC3G incorporation into human immunodeficiency virus type 1 particles
W Zennou et al.
JOURNAL OF VIROLOGY (2004)
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
K Luo et al.
JOURNAL OF VIROLOGY (2004)
Retroviral restriction by APOBEC proteins
RS Harris et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor
A Schäfer et al.
VIROLOGY (2004)
Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase
KM McBride et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
SG Conticello et al.
CURRENT BIOLOGY (2003)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
K Stopak et al.
MOLECULAR CELL (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
AID mediates hypermutation by deaminating single stranded DNA
SK Dickerson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase
R Bransteitter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business
JE Wedekind et al.
TRENDS IN GENETICS (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity
S Kao et al.
JOURNAL OF VIROLOGY (2003)
RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators
RS Harris et al.
MOLECULAR CELL (2002)
Global control of hepatitis B virus infection
JH Kao et al.
LANCET INFECTIOUS DISEASES (2002)
AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization
C Rada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22
A Jarmuz et al.
GENOMICS (2002)
Molecular mechanisms of apolipoprotein B mRNA editing
S Anant et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene
T Muto et al.
GENOMICS (2000)
An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1:: Binding of Apobec-1 to this motif in the 3′ untranslated region of c-myc increases mRNA stability
S Anant et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
M Muramatsu et al.
CELL (2000)
Share Paper
